Volume 24, Issue 3 (6-2025)
JRUMS 2025, 24(3): 258-270 |
Back to browse issues page
Ethics code: IR.JMU.REC.1403.013
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hushmandi K, Nikvarz M, Vazirinasab H, Ardaneh M, Barkhori E, Khazaee-Nasirabadi M H, et al . Investigating the Epidemiological Characteristics and Risk Factors of Hepatitis B and C Infections in the High-Risk Population of the Cities Covered by Jiroft University of Medical Sciences During the Years 2014-2023: A Descriptive Study. JRUMS 2025; 24 (3) :258-270
URL: http://journal.rums.ac.ir/article-1-7531-en.html
URL: http://journal.rums.ac.ir/article-1-7531-en.html
Kiavash Hushmandi 
, Mehran Nikvarz , Habibe Vazirinasab , Mahdieh Ardaneh , Esmaeil Barkhori , Mohammad Hossein Khazaee-Nasirabadi , Vahid Mashayekhimazar , Salman Daneshi
, Mehran Nikvarz , Habibe Vazirinasab , Mahdieh Ardaneh , Esmaeil Barkhori , Mohammad Hossein Khazaee-Nasirabadi , Vahid Mashayekhimazar , Salman Daneshi
Abstract: (147 Views)
Investigating the Epidemiological Characteristics and Risk Factors of Hepatitis B and C Infections in the High-Risk Population of the Cities Covered by Jiroft University of Medical Sciences During the Years 2014-2023: A Descriptive Study
Kiavash Hushmandi[1], Mehran Nikvarz[2], Habibeh Vazirinasab[3], Mahdieh Ardaneh[4], Esmaeil Barkhori[5], Mohammad Hossein Khazaee Nasirabadi[6], Vahid Mashayekhimazar[7], Salman Daneshi[8]
Received: 14/010/24 Sent for Revision: 30/03/24 Received Revised Manuscript: 10/05/25 Accepted: 11/05/25
Background and Objectives: Hepatitis B (HBV) and C (HCV) viruses are the leading causes of liver failure and hepatocellular carcinoma (HCC). Estimates indicate that approximately 350 million people worldwide are infected with HBV and 170 million with HCV. Transmission of these viruses occurs mainly through blood, sexual contact, and mother-to-infant transmission. This study aimed to determine the epidemiology of HBV and HCV infections in high-risk populations in the cities covered by Jiroft University of Medical Sciences during the years 2014 to 2023.
Materials and Methods: This study was conducted in a descriptive-cross-sectional manner. Data were collected from HBV and HCV carriers reported to health networks of Jiroft University of Medical Sciences in a census manner. The data collection tool included checklists with demographic and clinical variables. The findings were reported in the form of descriptive statistics.
Results: A total of 1,382 patients with hepatitis B and C were studied. The mean and standard deviation of the age of the patients was 38.13±51.81 years. The frequency of HBV in women (60.6%) was higher than that of men (39.4%), while the frequency of HCV was reported to be higher in men (78.1%). Also, frequency of both types of hepatitis was observed more in married individuals.
Conclusion: The results of this study indicate the need to pay more attention to the risk factors associated with HBV and HCV infections. The collected information can be used to develop national policies to prevent and control these diseases.
Keywords: Hepatitis B, Hepatitis C, Epidemiology, Risk factors, High-risk population, Jiroft
Funding: This study did not have any funds.
Conflict of interest: None declared.
Ethical considerations: The Ethics Committee of Jiroft University of Medical Sciences approved the study (IR.JMU.REC.1403.013).
Author’s contributions:
- Conceptualization: Kiavash Hushmandi, Salman Daneshi
- Methodology: Mahdieh Ardaneh, Vahid Mashayekhimazar
- Data collection: Esmaeil Barkhori, Mohammad Hossein Khazaee Nasirabadi
- Formal analysis: Mehran Nikvarz, Habibeh Vazirinasab, Vahid Mashayekhimazar
- Supervision: Kiavash Hushmandi, Salman Daneshi
- Project administration: Salman Daneshi
- Writing - original draft: Mehran Nikvarz, Mahdieh Ardaneh, Mohammad Hossein Khazaee-Nasirabadi
- Writing - review & editing: Kiavash Hushmandi, Salman Daneshi
Kiavash Hushmandi[1], Mehran Nikvarz[2], Habibeh Vazirinasab[3], Mahdieh Ardaneh[4], Esmaeil Barkhori[5], Mohammad Hossein Khazaee Nasirabadi[6], Vahid Mashayekhimazar[7], Salman Daneshi[8]
Received: 14/010/24 Sent for Revision: 30/03/24 Received Revised Manuscript: 10/05/25 Accepted: 11/05/25
Background and Objectives: Hepatitis B (HBV) and C (HCV) viruses are the leading causes of liver failure and hepatocellular carcinoma (HCC). Estimates indicate that approximately 350 million people worldwide are infected with HBV and 170 million with HCV. Transmission of these viruses occurs mainly through blood, sexual contact, and mother-to-infant transmission. This study aimed to determine the epidemiology of HBV and HCV infections in high-risk populations in the cities covered by Jiroft University of Medical Sciences during the years 2014 to 2023.
Materials and Methods: This study was conducted in a descriptive-cross-sectional manner. Data were collected from HBV and HCV carriers reported to health networks of Jiroft University of Medical Sciences in a census manner. The data collection tool included checklists with demographic and clinical variables. The findings were reported in the form of descriptive statistics.
Results: A total of 1,382 patients with hepatitis B and C were studied. The mean and standard deviation of the age of the patients was 38.13±51.81 years. The frequency of HBV in women (60.6%) was higher than that of men (39.4%), while the frequency of HCV was reported to be higher in men (78.1%). Also, frequency of both types of hepatitis was observed more in married individuals.
Conclusion: The results of this study indicate the need to pay more attention to the risk factors associated with HBV and HCV infections. The collected information can be used to develop national policies to prevent and control these diseases.
Keywords: Hepatitis B, Hepatitis C, Epidemiology, Risk factors, High-risk population, Jiroft
Funding: This study did not have any funds.
Conflict of interest: None declared.
Ethical considerations: The Ethics Committee of Jiroft University of Medical Sciences approved the study (IR.JMU.REC.1403.013).
Author’s contributions:
- Conceptualization: Kiavash Hushmandi, Salman Daneshi
- Methodology: Mahdieh Ardaneh, Vahid Mashayekhimazar
- Data collection: Esmaeil Barkhori, Mohammad Hossein Khazaee Nasirabadi
- Formal analysis: Mehran Nikvarz, Habibeh Vazirinasab, Vahid Mashayekhimazar
- Supervision: Kiavash Hushmandi, Salman Daneshi
- Project administration: Salman Daneshi
- Writing - original draft: Mehran Nikvarz, Mahdieh Ardaneh, Mohammad Hossein Khazaee-Nasirabadi
- Writing - review & editing: Kiavash Hushmandi, Salman Daneshi
[1]- Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
[2]- Assistant Prof. of Pediatrics, Dept. of Pediatrics, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran
[3]- Dept. of Biostatistics and Epidemiology, School of Health, Kerman University of Medical Sciences, Kerman, Iran
[4]- PhD Student, Dept. of Epidemiology, School of Health, Tehran University of Medical Sciences, Tehran, Iran
[5]- MSc Student, Faculty of Nursing and Midwifery, Iran University of Medical Science, Tehran, Iran
[6]- Dept. of Medical Laboratory Sciences, School of Allied Medical Sciences, Jiroft University of Medical Sciences, Jiroft, Iran
[7]- Dept. of Public Health, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran
[8]- PhD, Assistant Prof., Dept. of Public Health, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran,
ORCID: 0000-0002-9199-0382
(Corresponding Author) Tel: (034) 43316379, E-mail: salmandaneshi008@gmail.com,
ORCID: 0000-0002-9199-0382
(Corresponding Author) Tel: (034) 43316379, E-mail: salmandaneshi008@gmail.com,
Type of Study: Research |
Subject:
Statistics& Epidemiology
Received: 2024/10/13 | Accepted: 2025/05/11 | Published: 2025/06/20
Received: 2024/10/13 | Accepted: 2025/05/11 | Published: 2025/06/20
References
1. Muljono DH. Epidemiology of hepatitis B and C in Republic of Indonesia. Euroasian Journal of Hepato-Gastroenterology 2017; 7(1): 55.
2. Ayele A, Abera D, Hailu M, Birhanu M, Desta K. Prevalence and associated risk factors for Hepatitis B and C viruses among refugees in Gambella, Ethiopia. BMC Public Health 2020; 20: 1-10.
3. Ruggieri A, Gagliardi MC, Anticoli S. Sex-dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses? Frontiers in Immunology 2018; 9: 2302.
4. Drazilova S, Janicko M, Kristian P, Schreter I, Halanova M, Urbancikova I, et al. Prevalence and risk factors for hepatitis B virus infection in Roma and non-Roma people in Slovakia. International Journal of Environmental Research and Public Health. 2018; 15(5): 1047.
5. Al-Humayed SM. Hepatitis B and C viral infections in Tihamet Aseer, South-western Saudi Arabia: are there gender differences? Saudi Journal of Medicine & Medical Sciences 2017; 5(2): 110-5.
6. Hassani P, Ezbarami ZT, Tafreshi MZ, Majd HA. A Qualitative Study on Marital Challenges of Chronic Hepatitis B Patients. Iranian Red Crescent Medical Journal 2017; 19(8).
7. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clinical Microbiology and Infection 2015; 21(11): 1020-6.
8. Ward JW, Hinman AR. What is needed to eliminate hepatitis B virus and hepatitis C virus as global health threats. Gastroenterology 2019; 156(2): 297-310.
9. Sheena BS, Hiebert L, Han H, Ippolito H, Abbasi-Kangevari M, Abbasi-Kangevari Z, et al. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The lancet Gastroenterology & Hepatology 2022; 7(9): 796-829.
10. Cui F, Blach S, Mingiedi CM, Gonzalez MA, Alaama AS, Mozalevskis A, et al. Global reporting of progress towards elimination of hepatitis B and hepatitis C. The lancet Gastroenterology & Hepatology. 2023; 8(4): 332-42.
11. Sajjadi SM, Pourfathollah AA, Mohammadi S, Nouri B, Hassanzadeh R, Fariba R. The prevalence and trends of hepatitis B, hepatitis C, and HIV among voluntary blood donors in kohgiluyeh and boyer-ahmad transfusion center, Southwestern Iran. Iranian Journal of Public Health. 2018; 47(7): 944.
12. Hajarizadeh B, Mesgarpour B, Nasiri MJ, Alavian SM, Merat S, Poustchi H, et al. Estimating the prevalence of hepatitis B virus infection and exposure among general population in Iran. Hepatitis Monthly 2017; 17(8): 11.
13. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. International Journal of Infectious Diseases 2009; 13(1): 9-19.
14. Meffre C, Le Strat Y, Delarocque‐Astagneau E, Dubois F, Antona D, Lemasson JM, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. Journal of Medical Virology 2010; 82(4): 546-55.
15. Mahboobi N, Porter SR, Karayiannis P, Alavian S-M. Dental treatment as a risk factor for hepatitis B and C viral infection. A review of the recent literature. Journal of Gastrointestinal and Liver Diseases 2013; 22(1): 79-86.
16. Pereira LM, Martelli CM, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso RMA, et al. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC infectious diseases 2013; 13: 1-12.
17. Mohd Suan MA, Said SM, Lim PY, Azman AZF, Abu Hassan MR. Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: A case–control study. PloS one 2019; 14(10): e0224459.
18. Anwar WA, El Gaafary M, Girgis SA, Rafik M, Hussein WM, Sos D, et al. Hepatitis C virus infection and risk factors among patients and health-care workers of Ain Shams University hospitals, Cairo, Egypt. Plos one 2021; 16(2): e0246836.
19. Ataei B, Alavian SM, Shahriari-Fard F, Rabiei AA, Safaei A, Rabiei A, et al. A case-control study of risk factors for hepatitis B infection: A regional report among Isfahanian adults. Journal of Research in Medical Sciences 2019; 24(1): 22.
20. Azarkar Z, Ziaee M, Ebrahimzadeh A, Sharifzadeh G, Javanmard D. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti‐hepatitis B core antigen alone subjects. Journal of Medical Virology 2019; 91(4): 615-22.
21. Mehmood S, Raza H, Abid F, Saeed N, Rehman HM, Javed S, et al. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. Journal of Public Health 2020; 28: 751-64.
22. Wang C, Ji D, Chen J, Shao Q, Li B, Liu J, et al. Hepatitis due to reactivation of hepatitis B virus in endemic areas among patients with hepatitis C treated with direct-acting antiviral agents. Clinical Gastroenterology and Hepatology 2017; 15(1): 132-6.
23. Chen G, Wang C, Chen J, Ji D, Wang Y, Wu V, et al. Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and meta‐analysis. Hepatology 2017; 66(1): 13-26.
24. Lin C-L, Kao J-H. Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants. Best Practice & Research Clinical Gastroenterology 2017; 31(3): 249-55.
25. Choi HS, Brouwer WP, Zanjir WM, de Man RA, Feld JJ, Hansen BE, et al. Nonalcoholic steatohepatitis is associated with liver‐related outcomes and all‐cause mortality in chronic hepatitis B. Hepatology 2020; 71(2): 539-48.
26. Wu VC-C, Chen T-H, Wu M, Huang C-H, Chen S-W, Cheng C-W, et al. Risk of cardiac arrhythmias in patients with chronic hepatitis B and C infections–A 13-year nationwide population-based study. Journal of Cardiology 2019; 74(4): 333-8.
27.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
